ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 3226 - 3240 of 5996 products
3SBio Approved to Market Once-Weekly Type 2 Diabetes Treatment in China
$5.00
Available
Biostage Raises $4.2 Million from China Investor for Bioengineered Organs
$5.00
Available
Sinobioway and F1 Oncology to Build Shenzhen CAR-T Manufacturing Facility
$5.00
Available
Shenzhen's HEC Pharm Invests in US Novel Imaging Contrast Company
$5.00
Available
CFDA Accepts Ascentage's IND Filing for Lead Drug in Hepatitis B
$5.00
Available
Ally Bridge and LifeTech Scientific Join to Invest in MedTech Companies
$5.00
Available
Simcere Acquires China Rights to Three Bi-Specific Immunoncology Drugs
$5.00
Available
Lepu Medical Pays $23.3 Million for 13% Stake in Australia's Viralytics
$5.00
Available
BeiGene to Generate New mAbs Using Harbour BioMed's Mouse Platform
$5.00
Available
Berry Genomics Collaborates with 10X Genomics for Next-Gen Prenatal Tests
$5.00
Available
Jiangsu Hengrui Out-Licenses Novel Dermatology Drug for $233 Million
$5.00
Available
China's KBP Closes $76 Million A Round; Opens Philadelphia Global Headquarters
$5.00
Available
Genetron Health Raises $61 Million for Genomics-Oncology Services
$5.00
Available
Zhejiang DTRM Completes $60 Million A Round for US-China Clinical Trials
$5.00
Available
iCarbonX Leads $200 Million Funding in SomaLogic of Colorado
$5.00
Available